News

U.S. drugmaker Bristol Myers Squibb announced on Monday a $1.5 billion upfront payment to partner with Germany's BioNTech , ...
A study has revealed why some patients don't respond to immune checkpoint blockade (ICB) therapy for solid cancer tumors and ...
The oncology giant will pay $1.5 billion to co-develop a BioNTech drug that targets the proteins PD-L1 and VEGF, following ...
Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), 61 Biopolis Drive, Proteos, Singapore 138673, Singapore ...
An amenity centre will be set up at the newly constructed Cochin Cancer Research Centre at Kalamassery. The facility is expected to provide stay and rest options for bystanders, according to P.
the Cambridge Biomedical Campus. It will bring clinical expertise from Addenbrooke's Hospital with world-class scientists from the University of Cambridge, Cancer Research UK Cambridge Centre, and ...
THE new multi-million pound Cancer Focus centre will officially open in Enniskillen this month in what will be a major boost to people living with cancer in Fermanagh and their families. Major work ...
The Food and Drug Administration on Friday approved the first at-home test to screen for cervical cancer, Teal Health, which makes the test kit, said. Currently, cervical cancer screening is done ...
Moffitt Cancer Center will no longer fly a rainbow flag in June to commemorate pride month, according to internal emails obtained by the Tampa Bay Times. The nonprofit also will not fly a special ...
If skincare is your specialty, associating your brand with desiccated human flesh is probably unwise. Here's the face of what people are reporting: Medcare Skin Centre, a Ho Chi Minh City-based ...
Brad Arnold, singer for the band 3 Doors Down, shared his stage 4 kidney cancer diagnosis this week, revealing that doctors discovered the cancer after he'd felt sick and been in the hospital.
Algorae Pharmaceuticals (ASX: 1AI) has partnered with the Victorian Centre for Functional Genomics (VCFG) at the Peter MacCallum Cancer Centre in Melbourne to validate AI-predicted drug synergies ...